Objective
Increasing evidence supports the" inflammatory hypothesis in AD" according to which neuronal damages in this age-related disease are caused not only by the fundamental pathology but also by the local inflammatory response to it sustained by reactive glib. Recent findings demonstrate a sophisticated integration between neurons and atrocities. Inflammatory atrocities undergo morph functional changes, which may perturb neuron-atrocity interaction and result in neuronal sufferance. By identifying and targeting harmful pathways in inflammatory atrocities we will define potential new therapeutic approaches to prevent or delay AD progression. This consortium combines complementary expertise to: a) assess the "inflammatory hypothesis of AD" and the role of atrocities in transgenic models; b) identify targets of inflammation-neurodegeneration coupling in atrocities; c) validate drug strategies against them; d) test these therapeutically strategies in AD transgenic.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesbasic medicinepathology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
75654 PARIS
France